Search research articles
Contact Us
Filters
Showing results (1-10 of 31) with videos related to
Page
of 4
Sort By:
BMJ Open Ophthalmology
|
March 28, 2022
Fluctuations in central foveal thickness and association with vision outcomes with anti-VEGF therapy for nAMD: HARBOR post hoc analysis
Veeral Sheth, Mitchell D'Rozario, Shamika Gune, et al.
Ophthalmology. Retina
|
May 1, 2020
Agreement of Spectral-Domain OCT with Fluorescein Leakage in Neovascular Age-Related Macular Degeneration: Post Hoc Analysis of the HARBOR Study
Rahul N Khurana, Lauren Hill, Avanti Ghanekar, et al.
American Journal of Ophthalmology
|
November 28, 2024
Refillable Drug Reservoirs for Retinal Vascular Diseases
Andrew J Clark, Carl Regillo, Shamika Gune, et al.
Ophthalmology. Retina
|
May 4, 2019
Impact of Cataract Surgery during Treatment with Ranibizumab in Patients with Diabetic Macular Edema
Andrew A Moshfeghi, Howard Shapiro, Linda A Lemmon, et al.
Ophthalmology
|
March 20, 2016
Visual and Anatomic Outcomes in Patients with Diabetic Macular Edema with Limited Initial Anatomic Response to Ranibizumab in RIDE and RISE
Dante J Pieramici, Pin-Wen Wang, Beiying Ding, et al.
Ophthalmology. Retina
|
November 13, 2022
Characteristics that Correlate with Macular Atrophy in Ranibizumab-Treated Patients with Neovascular Age-Related Macular Degeneration
Giovanni Staurenghi, Mariano Cozzi, SriniVas Sadda, et al.
Ophthalmic Surgery, Lasers & Imaging Retina
|
April 30, 2020
Long-Term Vision Outcomes in Patients With DME and a Limited Early Visual Response to Ranibizumab in RIDE and RISE
Rishi P Singh, Dante J Pieramici, Pin-Wen Wang, et al.
Ophthalmology. Retina
|
April 15, 2022
Prevalence and Progression of Macular Atrophy in Eyes with Neovascular Age-Related Macular Degeneration in the Phase 2 Ladder Trial of the Port Delivery System with Ranibizumab
Glenn J Jaffe, Briana Cameron, David Kardatzke, et al.
Journal of Vitreoretinal Diseases
|
April 3, 2023
Implantation Site of a Port Delivery System With Ranibizumab: Anterior Segment Optical Coherence Tomography Evaluation
Connor J Ericksen, Cory A Christensen, Brian Berger, et al.
Ophthalmology. Retina
|
February 27, 2025
Macular Atrophy-Related Observations in Eyes Treated with the Port Delivery System with Ranibizumab in the Archway Trial
Glenn J Jaffe, Briana Cameron, Giulio Barteselli, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 31) with videos related to
Sort By:
Page
of 4
BMJ Open Ophthalmology
|
March 28, 2022
Fluctuations in central foveal thickness and association with vision outcomes with anti-VEGF therapy for nAMD: HARBOR post hoc analysis
Veeral Sheth, Mitchell D'Rozario, Shamika Gune, et al.
Ophthalmology. Retina
|
May 1, 2020
Agreement of Spectral-Domain OCT with Fluorescein Leakage in Neovascular Age-Related Macular Degeneration: Post Hoc Analysis of the HARBOR Study
Rahul N Khurana, Lauren Hill, Avanti Ghanekar, et al.
American Journal of Ophthalmology
|
November 28, 2024
Refillable Drug Reservoirs for Retinal Vascular Diseases
Andrew J Clark, Carl Regillo, Shamika Gune, et al.
Ophthalmology. Retina
|
May 4, 2019
Impact of Cataract Surgery during Treatment with Ranibizumab in Patients with Diabetic Macular Edema
Andrew A Moshfeghi, Howard Shapiro, Linda A Lemmon, et al.
Ophthalmology
|
March 20, 2016
Visual and Anatomic Outcomes in Patients with Diabetic Macular Edema with Limited Initial Anatomic Response to Ranibizumab in RIDE and RISE
Dante J Pieramici, Pin-Wen Wang, Beiying Ding, et al.
Ophthalmology. Retina
|
November 13, 2022
Characteristics that Correlate with Macular Atrophy in Ranibizumab-Treated Patients with Neovascular Age-Related Macular Degeneration
Giovanni Staurenghi, Mariano Cozzi, SriniVas Sadda, et al.
Ophthalmic Surgery, Lasers & Imaging Retina
|
April 30, 2020
Long-Term Vision Outcomes in Patients With DME and a Limited Early Visual Response to Ranibizumab in RIDE and RISE
Rishi P Singh, Dante J Pieramici, Pin-Wen Wang, et al.
Ophthalmology. Retina
|
April 15, 2022
Prevalence and Progression of Macular Atrophy in Eyes with Neovascular Age-Related Macular Degeneration in the Phase 2 Ladder Trial of the Port Delivery System with Ranibizumab
Glenn J Jaffe, Briana Cameron, David Kardatzke, et al.
Journal of Vitreoretinal Diseases
|
April 3, 2023
Implantation Site of a Port Delivery System With Ranibizumab: Anterior Segment Optical Coherence Tomography Evaluation
Connor J Ericksen, Cory A Christensen, Brian Berger, et al.
Ophthalmology. Retina
|
February 27, 2025
Macular Atrophy-Related Observations in Eyes Treated with the Port Delivery System with Ranibizumab in the Archway Trial
Glenn J Jaffe, Briana Cameron, Giulio Barteselli, et al.
Page
of 4